Literature DB >> 2751141

Effect of propranolol on the first pass uptake of fentanyl in the human and rat lung.

D L Roerig1, K J Kotrly, S B Ahlf, C A Dawson, J P Kampine.   

Abstract

The first pass uptake of fentanyl in the human lung was studied in two groups of patients using a double indicator dilution technique. A bolus containing fentanyl and indocyanine green dye (ICG) was rapidly injected into the central venous catheter of patients prior to anesthesia. Sequential arterial blood samples were collected at 1-s intervals for 45 s after injection. The total amount of fentanyl taken up by the lung during the first pass and the instantaneous extraction of fentanyl at each time point during the first pass were calculated from the differences in the arterial blood concentration versus time curves of the nondiffusible indicator (ICG) and the drug. In patients who had been receiving no other drugs prior to the experiment, the total first pass uptake (mean +/- SE) of fentanyl was 82.6% +/- 1.4% of the injected dose. In patients who had been receiving 30-120 mg/day of propranolol the total first pass uptake (mean +/- SE) of fentanyl decreased to 52.8% +/- 6.3% of the injected dose. In one patient on 120 mg of propranolol per day, first pass uptake of fentanyl was only 20.3% of the injected dose. Additional studies in a rat isolated perfused lung preparation coperfused with fentanyl and propranolol also demonstrated that one basic lipophilic amine (propranolol) could inhibit the pulmonary uptake of a second basic lipophilic amine (fentanyl). The high first pass uptake of fentanyl in the human lung limits the rate of entry of this drug into the systemic circulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751141     DOI: 10.1097/00000542-198907000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Pulmonary distribution of alfentanil and sufentanil studied with system dynamics analysis.

Authors:  F Boer; A Hoeft; M Scholz; J G Bovill; A G Burm; A Hak
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

Review 2.  Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.

Authors:  J Scholz; M Steinfath; M Schulz
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

3.  Quantification of mitochondrial membrane potential in the isolated rat lung using rhodamine 6G.

Authors:  Said H Audi; Anthony Cammarata; Anne V Clough; Ranjan K Dash; Elizabeth R Jacobs
Journal:  J Appl Physiol (1985)       Date:  2020-03-05

4.  Cardiac Arrest Upon Induction of General Anesthesia.

Authors:  Regina A E Dowdy; Shadee T Mansour; James H Cottle; Hannah R Mabe; Harry B Weprin; Leigh E Yarborough; Gregory M Ness; Todd M Jacobs; Bryant W Cornelius
Journal:  Anesth Prog       Date:  2021-03-01

5.  Displacement of lidocaine from the lung after bolus injection of bupivacaine.

Authors:  S Ohmura; K Yamamoto; T Kobayashi; S Murakami
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

6.  Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery.

Authors:  L E Mather; A Woodhouse; M E Ward; S J Farr; R A Rubsamen; L G Eltherington
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

7.  Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models.

Authors:  S Björkman; D R Wada; D R Stanski; W F Ebling
Journal:  J Pharmacokinet Biopharm       Date:  1994-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.